ÂÜÀòÂÒÂ×

Mark Lieberman is the President & Co-Founder of Force Therapeutics. Mark received his MBA from Harvard Business School and BS in Genetic Engineering from Princeton University. Mark's leadership in health care innovation spans roles as a senior business development executive at Merck & Co, an executive at the biopharmaceutical company, Imclone Systems, and as a health care investment banking partner at Montgomery Securities. For the last 15 years, Mark has been a serial entrepreneur and private equity investment partner. He co-founded Thomas Weisel Capital Partners, a $2.5 Billion Private Equity firm, served on its operating committee and became co-head of Tailwind Capital Partners, its venture capital arm. Separately, Mark is a three time Emmy nominated TV producer and creator of one of the longest running arts TV series on PBS which has shaped the quality of educational and animated content at Force.